Literature DB >> 22935295

Generic anti-drug antibody assay with drug tolerance in serum samples from mice exposed to human antibodies.

Kay Stubenrauch1, Klaus Mackeben, Rudolf Vogel, Julia Heinrich.   

Abstract

Knowledge of the anti-drug antibody (ADA) status is necessary in early research studies. Because specific assay materials are sparse and time is pressing, a generic assay format with drug tolerance for detection of ADAs in serum samples from mice exposed to immunoglobulin G (IgG) or antigen-binding fragments (Fabs) is highly desirable. This article describes a generic immune complex assay in the sandwich enzyme-linked immunosorbent assay (ELISA) format based on (i) transformation of free ADAs to immune complexes by preincubation with excess drug, (ii) the use of a murine anti-human Fab constant domain Fab as capture reagent, (iii) detection of the immune complexes by a peroxidase-labeled rabbit anti-murine Fc antibody, and (iv) ADA-positive control conjugates consisting of human Fab and murine IgG. Results of the experiments suggest that the generic immune complex assay for mouse serum samples was at least equivalent to specific ADA immune assays and even superior regarding drug tolerance. The generic immune complex assay confers versatility as it detects ADAs in complex with full-length IgG as well as with Fabs independent of the target specificity in mouse serum samples. These features help to save the sparse amounts of specific antibodies available in early research and development and speed up drug candidate selection.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22935295     DOI: 10.1016/j.ab.2012.08.022

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  4 in total

Review 1.  Approaches for the detection and analysis of antidrug antibodies to biopharmaceuticals: A review.

Authors:  Kyungah Suh; Isaac Kyei; David S Hage
Journal:  J Sep Sci       Date:  2022-03-10       Impact factor: 3.614

2.  Neonatal Immune Tolerance Induction to Allow Long-Term Studies With an Immunogenic Therapeutic Monoclonal Antibody in Mice.

Authors:  Matthieu Piccand; Juliana Bessa; Eginhard Schick; Claudia Senn; Carole Bourquin; Wolfgang F Richter
Journal:  AAPS J       Date:  2015-11-24       Impact factor: 4.009

Review 3.  Emerging Technologies and Generic Assays for the Detection of Anti-Drug Antibodies.

Authors:  Michael A Partridge; Shobha Purushothama; Chinnasamy Elango; Yanmei Lu
Journal:  J Immunol Res       Date:  2016-07-31       Impact factor: 4.818

Review 4.  Current Analytical Strategies for Antibody-Drug Conjugates in Biomatrices.

Authors:  Qiuping Qin; Likun Gong
Journal:  Molecules       Date:  2022-09-24       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.